Ziping Wei

Ziping Wei

Company: Bliss Bio

Job title: Chief Executive Officer


Dr. Ziping Wei is co-founder and Chief Executive Officer of Bliss Biopharmaceutical Co., Ltd. focusing on the development of biologics in targeted therapy and immune-oncology areas. She has had over twenty-two years of industrial experience in biotechnology and biopharmaceutical development and commercialization in US and has extensive experience in CMC development of antibody and vaccine products. She held positions in biopharmaceutical development as Executive Director at Novavax, Inc., Scientific Director at MedImmune, AstraZeneca, and Senior Scientist at Bristol-Myers Squibb and Johnson & Johnson. She is familiar with process and product development, and cGMP practices, and has supported numerous global regulatory filings for clinical and commercial products. She is a highly experienced executive who has managed cross-functional teams. She has co-authored 30+ journal publications, patents, and book chapters, and 80+ scientific abstracts, presentations, and short courses at national and international conferences. Dr. Wei is a member of Board of Director and former president (2014-2015) of Chinese Biopharmaceutical Association-USA (CBA). She received her Ph.D. in Chemistry at Rutgers, the State University of New Jersey, and B.S. in Chemistry at the University of Science and Technology of China.

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.